chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: FLUX
Symptoms: Local reaction, Malaise, Pruritus
Clinical narrative: Case number PHHY2017US018298, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (VAERS reference number: 664359) website on 23 Jan 2017. This report refers to a 55 years old female patient. Past medical history was not reported. Concomitant medications included as metoprolol, omeprazole and ZYRTEC. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer and batch number: not reported) into arm on 03 Nov 2016. On 04 Nov 2016, the patient experienced pain in her arm, site were shot was given from raised, red, itchy and painful, large orange shaped circle around the injection site, felt ill went to bed. Patient still a bruise and some itching on 04 Nov 2016. The next morning she called physicians office and they advised her to come to urgent care. Seen physician he diagnosed as localized reaction. Physician gave her prednisone and told her to take antihistamines. Patient swelling was greatly reduced after a few hours of prednisone. The patient visited the emergency room. The outcome of the events was reported as condition unchanged. The seriousness and causality of the events were not reported.
Age: 12.0
Sex: M
Vaccine: FLUX, HPVX
Symptoms: Dizziness
Clinical narrative: Case number PHHY2017US014651, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (VAERS reference number: 664368) website on 23 Jan 2017. This report refers to a 12 years old male patient. Past medical history was not reported. Concomitant medications included as Childrens ZYRTEC and Childrens vitamin. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer and batch number: not reported) into left arm on 05 Nov 2016. The patient also vaccinated with human papilloma virus vaccine (other manufacture and batch number: not reported) into right arm on 05 Nov 2016. On the same day after vaccination, the patient became dizzy and nearly fainted. The outcome of the events was reported as complete recovery on an unknown date. The seriousness and causality of the events were not reported. The seriousness assessment of dizziness was upgraded to serious (medically significant) based on the information available in the source document.
Age: 16.0
Sex: F
Vaccine: FLUX
Symptoms: Pain in extremity
Clinical narrative: Case number PHHY2017US019720 is an initial spontaneous report received from a consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 664388) website on 23 Jan 2017. This report refers to a 16 year old female patient. Prior vaccination history included vaccination with meningococcal vaccine (manufacturer unknown, batch number: not reported) and was well tolerated. Medical history and concomitant medication were not reported. The patient was vaccinated with INN (unknown whether seasonal or pandemic, manufacturer and batch number: not reported) on an unknown date. After vaccination, on an unspecified date, the patient experienced pain in extremity. The outcome, seriousness and causality of the event were not reported.
Age: 67.0
Sex: M
Vaccine: FLUX
Symptoms: Chills, Pyrexia
Clinical narrative: Case number PHHY2017US016754, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 664417) on 23 Jan 2017. This report refers to a 67 years old male patient. Historical condition included prostate cancer. Current conditions included kidney disease and heart disease. Concomitant medication included COZAAR, Baby Aspirin, Adult Multivitamin, Vitamin D 2000, fish oil. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer unknown, batch number: not reported) on 28 Oct 2016. On same day after vaccination, the patient experienced chills and fever with body temperature 101 (units unspecified). The outcome of the events was not reported. The seriousness of the events was reported as non serious and causality was not reported.
Age: 63.0
Sex: F
Vaccine: FLUX
Symptoms: Headache, Rash, Rash pruritic
Clinical narrative: Case number PHHY2017US017131, is an initial spontaneous report received from via Vaccine Adverse Event Reporting System (VAERS reference number: 664549) website on 23 Jan 2017. This report refers to 63 years old female. The patient was vaccinated with INN (unknown manufacturer, batch number: not reported) at 14:20 pm on 22 Oct 2016. On the same day after vaccination the patient experienced dull headache for 03 days and experienced itchy rash to the torso and right arm three days after flu shot. The outcome of the events was reported as condition unchanged. The seriousness and causality of the events were not reported.
Sex: F
Vaccine: FLUX
Symptoms: Pain in extremity
Clinical narrative: Case number PHHY2017US017237, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (VAERS reference number: 664553) website on 23 Jan 2017. This report refers to a female patient of unspecified age. Past medical history was not reported. The patient's vaccination history included had flu shot in past however never hurt. Concomitant medications were not reported. The patient was vaccinated with seasonal influenza virus vaccine INN (unknown manufacturer, batch  number: not reported) on an unspecified age. On an unspecified date after vaccination the patient experienced pain in arm for 03 weeks. The outcome of the events was reported as complete recovery on an unspecified date. The seriousness and causality of the events were not reported.
Age: 67.0
Sex: M
Vaccine: FLUX, PPV
Symptoms: Injection site swelling, Pyrexia
Clinical narrative: Case number PHHY2017US017613, is an initial spontaneous report received from a pharmacist via Vaccine Adverse Event Reporting System (VAERS reference number: 664563) website on 23 Jan 2017. This report refers to a 67 years old male patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza virus vaccine INN (manufacturer unknown, batch number: not reported) intramuscularly in left arm on 19 Oct 2016. The patient was also vaccinated with PNEUMOVAX (batch number M020521, expiry date: 17 Nov 2017) intramuscularly in right arm on 19 Oct 2016. On 20 Oct 2016 after vaccination the patient experienced swelling from injection in right arm down to elbow and also felt feverish. There was no treatment given. The outcome of injection site swelling, peripheral swelling and pyrexia was reported as condition unchanged. The seriousness and causality of the events were not reported.
Age: 89.0
Sex: M
Vaccine: FLUX
Symptoms: Asthenia, Dizziness
Clinical narrative: Case number PHHY2017US027274, is an initial spontaneous report received from via Vaccine Adverse Event Reporting System (VAERS reference number: 664572) website on 23 Jan 2017. This report refers to an 89 years old male patient of unspecified age, Past medical history and concomitant medications were not reported. The patient was vaccinated with INN (unknown manufacturer, batch number: not reported) on 10 Oct 2016. On an unspecified date after vaccination the patient experienced extremely dizzy and weak. The outcome of the events was reported as complete recovery on an unspecified date. The seriousness and causality of the events were not reported.
Age: 66.0
Sex: M
Vaccine: FLUX
Symptoms: Pain in extremity
Clinical narrative: Case number PHHY2017US010646, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 664588) on 23 Jan 2017. This report refers to a 66 years old male patient. Medical history was not reported. Concomitant medication included lisinopril, amlodipine, CRESTOR, atenolol, Baby aspirin. The patient was vaccinated with first dose of seasonal influenza vaccine INN (manufacturer unknown, batch number: not reported) in to left arm on 16 Oct 2015. On 17 Oct 2015 after vaccination, the patient experienced intense sore/dull pain in upper arm. It continued after a few days. It was reported that, no tests were done but the patient reported to his cardiologist and family practice doctors over several month periods. The patient had delayed getting a flu shot this year because he was uncertain if he want to have the shot in the same arm and if additional adverse effects might happen. The outcome of the event was reported as condition unchanged. The seriousness of the event was reported as non serious and causality was not reported.
Age: 46.0
Sex: F
Vaccine: FLUX
Symptoms: Allergy to vaccine
Clinical narrative: Case number PHHY2017US018387 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 664740) website on 23 Jan 2017. This report refers to a 46 year old female patient. Past medical history and concomitant medication were not reported. The patient was vaccinated with influenza virus vaccine INN (unknown whether seasonal or pandemic, manufacturer and batch number: not reported) on an unknown date. On an unspecified date, it was reported that the patient was allergy to flu vaccine. The outcome, seriousness and causality of the event were not reported.
Age: 76.0
Sex: F
Vaccine: FLUX
Symptoms: Erythema, Fatigue, Influenza like illness, Pain, Peripheral swelling
Clinical narrative: Case number PHHY2017US018345 is an initial spontaneous report received from other healthcare professional via vaccine adverse event reporting system (VAERS number: 664795) website on 23 Jan 2017. This report refers to  76 year old female patient. Medical history was not reported; current condition included allergic to sulpha drug, concomitant medication included as amlodipine besylate, irbesartan, simvastatin, HCTZ. The patient was vaccinated with INN (manufacturer unknown) on 04 Nov 2016. On the same day, the patient experienced extreme fatigue, body aches, flu like symptoms and swollen and red arm from elbow to shoulder. The symptoms lasted for three days. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious; causality of the events was not reported.
Age: 65.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Immediate post-injection reaction, Nuclear magnetic resonance imaging, Pain in extremity, Peripheral swelling, Ultrasound scan
Clinical narrative: Case number PHHY2017US017662 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 664859) website on 23 Jan 2017. This report refers to a 65 year old female patient. Medical history and concomitant medications were not reported. The patient was vaccinated with second dose of seasonal influenza virus vaccine INN (manufacturer unknown, batch number: not reported) into left arm on 23 Sep 2015. The patient was also vaccinated with PNEUMOVAX (manufacturer unknown, batch number: not reported) into left arm on 23 Sep 2015. After vaccination on 24 Sep 2015, the patient experienced very painful left arm and swelling immediately. On 08 Jan 2016, patient underwent MRI (nuclear magnetic resonance imaging) (results not specified). On 13 Jan 2016, patient underwent left humerus X-ray (results not specified). On 28 Jan 2016, patient underwent physical therapy. On 25 Feb 2016 patient received a corticosteroid injection. On 17 Jun 2016, patient underwent ultrasound of left and right arm (results not specified). It was reported that the patient received physical therapy on 24 Jun 2016, 30 Jun 2016, 06 Jul 2016 and 08 Jul 2016. The outcome of the events was reported as condition unchanged. The seriousness of the events was reported as non serious and causality was not reported.
Age: 65.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: X-ray limb
Clinical narrative: Case number PHHY2017US017662 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 664859) website on 23 Jan 2017. This report refers to a 65 year old female patient. Medical history and concomitant medications were not reported. The patient was vaccinated with second dose of seasonal influenza virus vaccine INN (manufacturer unknown, batch number: not reported) into left arm on 23 Sep 2015. The patient was also vaccinated with PNEUMOVAX (manufacturer unknown, batch number: not reported) into left arm on 23 Sep 2015. After vaccination on 24 Sep 2015, the patient experienced very painful left arm and swelling immediately. On 08 Jan 2016, patient underwent MRI (nuclear magnetic resonance imaging) (results not specified). On 13 Jan 2016, patient underwent left humerus X-ray (results not specified). On 28 Jan 2016, patient underwent physical therapy. On 25 Feb 2016 patient received a corticosteroid injection. On 17 Jun 2016, patient underwent ultrasound of left and right arm (results not specified). It was reported that the patient received physical therapy on 24 Jun 2016, 30 Jun 2016, 06 Jul 2016 and 08 Jul 2016. The outcome of the events was reported as condition unchanged. The seriousness of the events was reported as non serious and causality was not reported.
Age: 43.0
Sex: F
Vaccine: FLUX
Symptoms: Ear pain, Pain, Pain in jaw, Rash, Rash erythematous
Clinical narrative: Case number PHHY2017US017653, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (VAERS reference number: 664999) website on 23 Jan 2017. This report refers to a 43 years old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with first dose of seasonal influenza vaccine INN (manufacturer and batch number: not reported) into left arm on 08 Nov 2016. On 09 Nov 2016, the patient woke up aching all over - even scalp, jawline to right ear in pain like ear infection, pulsing pain in head above right ear and red bumps on forehead. The outcome of the events was reported as condition unchanged. The seriousness and causality of the events were not reported.
Age: 47.0
Sex: F
Vaccine: FLUX
Symptoms: Pruritus generalised, Rash, Urticaria
Clinical narrative: case number PHHY2017US019781, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (VAERS reference number: 665042) website on 23 Jan 2017. This report refers to a 47 years old female patient. Past medical history was not reported. Current conditions included as allergies-nuts, fruits, trees, grass, mold, weeds and sulfa. Concomitant medications included ALLERGRA and SINGULAIR. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer and batch number: not reported) into left arm (left upper arm) on 26 Oct 2016. On the same day after vaccination, the patient experienced rash, hives and itching over entire body from head to calves. It was reported that, progressively got worse until extra over the counter allergy medication was taken around 01:00 pm. Symptoms started to improve within 45 minutes after this. The outcome of the events was reported as complete recovery on an unknown date. The seriousness and causality of the events were not reported.
Age: 9.0
Sex: F
Vaccine: FLUX
Symptoms: Pruritus, Rash macular, Urticaria
Clinical narrative: Case number PHHY2017US017633 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 665068) website on 23 Jan 2017. This report refers to a 09 year old female patient. Prior vaccination history included vaccination with influenza (unknown whether seasonal or pandemic, other manufacturer) with no adverse effects (well tolerated). Medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza virus vaccine INN (manufacturer unknown, batch number: not reported) intramuscularly into left arm on 09 Nov 2016. On the same day after vaccination, patient developed hives which were noticed at about 6:00 PM and patient was treated with BENADRYL. It was reported that itching subsided but splotches were still there and remain in the morning of 10 Nov 2016 and reported as more medicines were given for treating itching. The outcome of the event urticaria was not reported and for the events pruritus and rash macular were reported as condition unchanged. The seriousness of the events was reported as non serious and causality was not reported.
Age: 12.0
Sex: M
Vaccine: FLUX
Symptoms: Fatigue, Headache, Nausea
Clinical narrative: Case number PHHY2017US017607 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 665095) website on 23 Jan 2017. This report a 12 year old male patient. Historical condition was not reported. Current condition included seasonal allergies. Concomitant medication included ZYRTEC. The patient was vaccinated with seasonal influenza virus vaccine INN (manufacturer unknown, batch number: not reported) on 08 Nov 2016. After vaccination on 09 Nov 2016, the patient experienced headache, fatigue and nausea. The final outcome of the events was reported as unknown. The event were assessed as non serious by the reporter and causality was not reported.
Age: 55.0
Sex: F
Vaccine: FLUX
Symptoms: Drug administered at inappropriate site, Malaise, Rash, Rash erythematous, Respiratory tract congestion
Clinical narrative: Case number PHHY2017US018767 is an initial spontaneous report received from a consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 665118) website on 23 Jan 2017. This report refers to a 55 year old female patient. Historical condition was not reported and current condition included allergy and cardiovascular disorder. It was reported that illness at the time of vaccination, pre-existing physician diagnosed allergies, birth defects and medical conditions were not reported. Concomitant medications included alirocumab. The patient was vaccinated with seasonal influenza virus vaccine INN (manufacturer unknown, batch number: not reported) on 03 Oct 2016 into abdomen. On the same day few minutes post vaccination, all of a sudden the patient got sick. On an unspecified date, post vaccination, the patient experienced cold and congestion. On 25 Oct 2016 (reported as Tuesday) 22 days post vaccination, the patient had little bitty rash on arm like a patch of little red bumps. Lab test and treatment were not reported. The outcome of the event rash erythematous was reported as complete recovery (reported as gone now) on an unknown date, the outcome of the event drug administration at inappropriate site was unknown and outcome of the other events was not reported. The seriousness of the events was reported as non serious and causality was not reported.
Age: 55.0
Sex: F
Vaccine: FLUX
Symptoms: Viral upper respiratory tract infection
Clinical narrative: Case number PHHY2017US018767 is an initial spontaneous report received from a consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 665118) website on 23 Jan 2017. This report refers to a 55 year old female patient. Historical condition was not reported and current condition included allergy and cardiovascular disorder. It was reported that illness at the time of vaccination, pre-existing physician diagnosed allergies, birth defects and medical conditions were not reported. Concomitant medications included alirocumab. The patient was vaccinated with seasonal influenza virus vaccine INN (manufacturer unknown, batch number: not reported) on 03 Oct 2016 into abdomen. On the same day few minutes post vaccination, all of a sudden the patient got sick. On an unspecified date, post vaccination, the patient experienced cold and congestion. On 25 Oct 2016 (reported as Tuesday) 22 days post vaccination, the patient had little bitty rash on arm like a patch of little red bumps. Lab test and treatment were not reported. The outcome of the event rash erythematous was reported as complete recovery (reported as gone now) on an unknown date, the outcome of the event drug administration at inappropriate site was unknown and outcome of the other events was not reported. The seriousness of the events was reported as non serious and causality was not reported.
Age: 55.0
Sex: F
Vaccine: FLUX, PER, UNK, VARZOS
Symptoms: Injection site discomfort, Injection site erythema, Injection site pruritus, Injection site reaction, Urticaria
Clinical narrative: Case number PHHY2017US018857 is an initial spontaneous report received from a consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 665287) website on 23 Jan 2017. This report refers to a 55 year old female patient. Historical condition was not reported and current condition included Augmentin allergy, Diabetes Mellitus, high blood pressure and thyroid disorder. Concomitant medications were not reported. The patient was vaccinated with seasonal influenza virus vaccine INN (manufacturer unknown, batch number: not reported) on 24 Oct 2016. The patient was also vaccinated with ZOSTAVAX (manufacturer unknown, batch number: not reported), pertussis vaccine (manufacturer unknown, batch number: not reported), hepatitis C vaccine and an unknown vaccine (name and details unspecified) on 24 Oct 2016. On the same day after vaccination, the patient reported that the area around injection site became red on the evening. It was reported that it was started out small and got larger since 25 Oct 2016. It was reported that on an unknown date, the affected area looked like a welt and was the size of a small apple and the area was red, itchy and uncomfortable. No lab tests were performed and patient did not seek medical attention. The outcome of the events were reported as unknown. The seriousness of the events was reported as non serious and causality was not reported.
Age: 35.0
Sex: F
Vaccine: FLUX
Symptoms: Chills, Injection site erythema, Injection site pruritus
Clinical narrative: Case number PHHY2017US017619 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 665332) website on 23 Jan 2017. This report a 35 year old female patient. Medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza virus vaccine INN (manufacturer unknown, batch number; not reported) on 07 Nov 2016. After vaccination on 10 Nov 2016, the patient experienced red around injection site, chills and injection site itchy. The outcome of the events was not reported. The seriousness of the events was reported as non serious and causality was not reported.
Age: 41.0
Sex: F
Vaccine: FLUX
Symptoms: Burning sensation, Chills, Erythema, Headache, Mass
Clinical narrative: Case number PHHY2017US018971 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 665350) website on 23 Jan 2017. This report refers to a 41 year old female patient. Medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza virus vaccine INN (manufacturer unknown, batch number: not reported) into left arm on 04 Nov 2016. On the same day after vaccination, patient experienced lump raised and progressively spread, red warm painful. It was reported that approximately 8 PM on the same day the patient consulted with a pharmacist and took BENADRYL and ZYRTEC for treatment. On the same day after vaccination, patient also experienced burning sensation across chest, stomach and thighs, redness continued to spread along with pain in forearm. On 05 Nov 2016, approximately at 5 PM patient visited urgent care. It was reported that, a 6cm by 6cm reaction of redness was seen in addition to swelling and pain and was prescribed with PEPCID in addition to BENADRYL and ZYRTEC. On 07 Nov 2016, patient experienced continued pain, muscle ache, weakness, chills and headache. On 09 Nov 2016, patient visited physician for follow up and was prescribed with MOBID and SUDAFED. It was reported that on an unknown date, the patient was diagnosed with vaccination reaction. The outcome of the events swelling and pain was reported as condition unchanged and for the other events was not reported. The seriousness of the events was reported as non serious and causality was not reported.
Age: 41.0
Sex: F
Vaccine: FLUX
Symptoms: Middle ear effusion, Muscular weakness, Myalgia, Pain, Pain in extremity
Clinical narrative: Case number PHHY2017US018971 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 665350) website on 23 Jan 2017. This report refers to a 41 year old female patient. Medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza virus vaccine INN (manufacturer unknown, batch number: not reported) into left arm on 04 Nov 2016. On the same day after vaccination, patient experienced lump raised and progressively spread, red warm painful. It was reported that approximately 8 PM on the same day the patient consulted with a pharmacist and took BENADRYL and ZYRTEC for treatment. On the same day after vaccination, patient also experienced burning sensation across chest, stomach and thighs, redness continued to spread along with pain in forearm. On 05 Nov 2016, approximately at 5 PM patient visited urgent care. It was reported that, a 6cm by 6cm reaction of redness was seen in addition to swelling and pain and was prescribed with PEPCID in addition to BENADRYL and ZYRTEC. On 07 Nov 2016, patient experienced continued pain, muscle ache, weakness, chills and headache. On 09 Nov 2016, patient visited physician for follow up and was prescribed with MOBID and SUDAFED. It was reported that on an unknown date, the patient was diagnosed with vaccination reaction. The outcome of the events swelling and pain was reported as condition unchanged and for the other events was not reported. The seriousness of the events was reported as non serious and causality was not reported.
Age: 41.0
Sex: F
Vaccine: FLUX
Symptoms: Skin warm, Swelling, Vaccination complication
Clinical narrative: Case number PHHY2017US018971 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 665350) website on 23 Jan 2017. This report refers to a 41 year old female patient. Medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza virus vaccine INN (manufacturer unknown, batch number: not reported) into left arm on 04 Nov 2016. On the same day after vaccination, patient experienced lump raised and progressively spread, red warm painful. It was reported that approximately 8 PM on the same day the patient consulted with a pharmacist and took BENADRYL and ZYRTEC for treatment. On the same day after vaccination, patient also experienced burning sensation across chest, stomach and thighs, redness continued to spread along with pain in forearm. On 05 Nov 2016, approximately at 5 PM patient visited urgent care. It was reported that, a 6cm by 6cm reaction of redness was seen in addition to swelling and pain and was prescribed with PEPCID in addition to BENADRYL and ZYRTEC. On 07 Nov 2016, patient experienced continued pain, muscle ache, weakness, chills and headache. On 09 Nov 2016, patient visited physician for follow up and was prescribed with MOBID and SUDAFED. It was reported that on an unknown date, the patient was diagnosed with vaccination reaction. The outcome of the events swelling and pain was reported as condition unchanged and for the other events was not reported. The seriousness of the events was reported as non serious and causality was not reported.
Sex: F
Vaccine: FLUX, PNC13
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Case number PHHY2017US019293, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 665542) website on 23 Jan 2017. This report refers to an elderly female patient (around 70 years old). Past medical history was not reported. Current condition included dementia. Concomitant medications were not reported. The patient was vaccinated with seasonal influenza virus vaccine INN (unknown manufacturer, batch number: not reported) in left arm on an unspecified date. The patient was also vaccinated with PREVNAR 13 (batch number: not reported) in right arm on an unspecified date. On an unspecified date after vaccination a patient experienced redness (about 3-4 inches in diameter) and swelling around the injection site. The redness and swelling was visible several days after vaccination but seemed to be improving with each day. The outcome of the events was reported as condition improving. It was unknown if the patient has shown similar reactions to other vaccines. The seriousness and causality of the events were not reported.
Age: 52.0
Sex: M
Vaccine: FLUX, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Case number PHHY2017US017624, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 665621) website on 23 Jan 2017. This report a 52 years old male patient. Past medical history was not reported. Current condition included type 2 diabetes and high blood pressure. Concomitant medications included TRULICITY, metformin, Pravastatin sodium, KLOR-CON, BYSTOLIC, INVOKANA and losartan and hydrochlorothiazide. The patient was vaccinated with seasonal influenza virus vaccine INN (manufacturer unknown, batch number: not reported) in right arm on 10 Nov 2016. The patient was also vaccinated with ZOSTAVAX (batch number not reported) in left arm on 10 Nov 2016. On 12 Nov 2016 after vaccination the patient experienced redness, soreness and itching at injection site. The outcome of the events was reported as condition unchanged. The seriousness and causality of the events were not reported.
Age: 48.0
Sex: M
Vaccine: FLUX
Symptoms: Back pain, Neck pain
Clinical narrative: Case number PHHY2017US017629, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 665623) website on 23 Jan 2017. This report refers to a 48 years old male patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza virus vaccine INN (manufacturer unknown, batch number: not reported) on 11 Nov 2016. On the same day after vaccination the patient experienced severe neck and lower back pain. The outcome of the events was reported as condition unchanged. The seriousness and causality of the events were not reported.
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2017US017647, is an initial spontaneous report received from Vaccine Event Reporting System (VAERS Reference number: 665653) website on 23 Jan 2017. This report refers to a 04 years old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza virus vaccine INN (manufacturer unknown, batch number: not reported in left leg on 11/10/2016. The patient also received vaccine with DTaP, (batch number: not reported) in right leg on 12 Nov 2016. On 12 Nov 2016 after vaccination the patient experienced redness heat and swelling around injection site appeared. The patient received treatment BENADRYL and applied hydrocortisone cream to site. The outcome of the events was reported as condition unchanged. The seriousness and causality of the events were not reported.
Age: 37.0
Sex: F
Vaccine: FLUX
Symptoms: Discomfort, Nausea, Pain
Clinical narrative: Case number PHHY2017US018012, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number 665661) website on 23 Jan 2017. This report refers to a 37 years old female patient. Past medical history was reported as none. Concomitant medication included Women's Multivitamins. Current condition was reported as none. She was vaccinated with seasonal influenza vaccine INN (manufacturer unknown, batch number not reported) into the right arm on 28 Oct  2016. After vaccination, on the same day, she experienced slight nausea, body aches in multiple areas that was bad enough that it required her to take a few breaths to encourage her body to move. Discomfort brought her to tears. Eventually she received a treatment with MOTRIN which helped a little. Next day her symptoms began to diminish. Final outcome of the events was reported as complete recovery on an unknown date. The seriousness and causality of the events were not reported.
Age: 63.0
Sex: M
Vaccine: FLUX
Symptoms: Dizziness postural
Clinical narrative: Case number PHHY2017US018077, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 665674) website on 23 Jan 2017. This report refers to a 63 years old male patient. Medical history was not reported. Concomitant medications included Metropolis, Fluoxetine, NORCO 5-325, Lisinopril, atorvastatin, omeprazole and loperamide hydrochloride. He was vaccinated with seasonal influenza vaccine INN (manufacturer unknown, batch number not reported) on the same day, he experienced dizziness when standing from a sitting position. No treatment was received for the event. The outcome of the vents was reported as complete recovery on an unknown date. The seriousness and causality of the event were not reported.
Age: 66.0
Sex: M
Vaccine: FLUX
Symptoms: Abdominal pain upper, Asthenia, Fatigue, Headache, Nausea
Clinical narrative: Case number PHHY2017US019016, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 665675) website on 23 Jan 2017. This report refers to a 66 years old male patient. Past medical history and concomitant medication were not reported. He was vaccinated with seasonal influenza vaccine INN (manufacturer unknown, batch number not reported) on 31 Oct 2016. After vaccination, on 01 Nov 2016, he experienced weakness, nausea, stomach cramps, extreme fatigue and headache. It was reported that the symptoms lasted for five days. The outcome of the events was reported as complete recovery on an unknown date. The seriousness and causality of the event were not reported.
Sex: M
Vaccine: FLUX
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: Case number PHHY2017US019109, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 665680) website on 23 Jan 2017. This report refers to a 56 years old male patient. Past medical history was not reported. Current condition included high blood pressure. Concomitant medications included losartan, Metoprolol, AVASTATIN, Aspirin and multivitamin. He was vaccinated with seasonal influenza vaccine INN (manufacturer unknown, batch number not reported) into the left arm on 19 Oct 2016. After vaccination, on the same day, he experienced ache in arm at injection site as well as the shoulder area. It was three and half weeks later and the shoulder pain was deep and severe. His arm movement was compromised. The outcome of the events was reported as condition unchanged. The seriousness and causality of the event were not reported.
Sex: M
Vaccine: FLUX
Symptoms: Pruritus, Urticaria
Clinical narrative: Case number PHHY2017US017922, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 665812) on 23 Jan 2017. This report refers to a 05 years old male patient. Historical condition was not reported. Current condition included asthma. Concomitant medication was not reported. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer unknown, batch number: not reported) on 07 Nov 2016. On same day after vaccination, the patient experienced hives and itching. The outcome of the events was reported as complete recovery. The seriousness of the events was reported as non serious and causality was not reported.
Age: 34.0
Sex: F
Vaccine: FLUX
Symptoms: Injected limb mobility decreased, Vaccination site pain
Clinical narrative: Case number PHHY2017US018735, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 665814) on 23 Jan 2017. This report refers to a 34 years old female patient. Medical history was not reported. Concomitant medication was not reported. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer unknown, batch number: not reported) into left arm on 31 Oct 2016. On same day after vaccination, the patient experienced extreme soreness in vaccination site of annual flu shot, it was more severe than any previous vaccine (unspecified) the patient received in the past and had limited mobility in arm. The patient thought it would lessened after 3 days. It was reported that, the overall soreness has continued for 14 days. The final outcome of the events was not reported. The seriousness of the events was reported as non serious and causality was not reported.
Age: 52.0
Sex: F
Vaccine: FLUX
Symptoms: Drug administered at inappropriate site, Insomnia, Laboratory test, Mobility decreased, Pain
Clinical narrative: Case number PHHY2017US019048, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference: 665857) on 23 Jan 2017. This report refers to a 52 years old female patient. Historical condition was not reported. Current condition included, the patient being treated for salmonella. Concomitant medication included ciprofloxacin hydrochloride. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer unknown, batch number: not reported) into right arm on 28 Sep 2016 and the vaccine was given very high on right arm/shoulder. On same day after vaccination, the patient thought was the standard soreness from a flu shot, however it turned into daily chronic pain, limited mobility, worsen symptoms at night when sleeping. The patient was treated with moist heat 2-4 times per day with 2000-3000 mg TYLENOL for pain from 28 Sep 2016 to 12 Oct 2016. On 12 Oct 2016, the patient was seen at the same urgent care clinic and was prescribed diclofenac 75 mg to take 2 per day in addition to Hydrocodone-Acetaminophen 5-325 for the pain. The patient refilled the diclofenac again on 05 Nov 2016. Laboratory data reveled that, the had TBD (unspecified). The patient continued to have chronic pain and lack of sleep and it was reported to clinic management. It was reported that, the patient would see the shoulder specialist on 16 Nov 2016. The final outcome of the events was reported as condition unchanged. The seriousness of the events was reported as non serious and causality was not reported.
Sex: U
Vaccine: FLUX, PNC13
Symptoms: Erythema, Swelling
Clinical narrative: Case number PHHY2017US018752, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 665878) on 23 Jan 2017. This report refers to a patient of an unknown age and gender. Medical history was not reported. Concomitant medication was not reported. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer unknown, batch number: not reported) and PREVNAR 13 (other manufacturer), batch number: not reported), both in the same arm on an unknown date. On an unknown date after vaccination, the patient experienced extreme redness and swelling. It was noted that, when injecting the influenza vaccine and pneumococcal 13-val conj vac (diphtheria CRM197 protein) in the same arm it was more prevalent. The outcome of the events was reported as unknown. The seriousness of the events was reported as non serious and causality was not reported.
Age: 59.0
Sex: F
Vaccine: FLUX
Symptoms: Chills, Headache, Hyperaesthesia, Hyperhidrosis, Oropharyngeal pain
Clinical narrative: Case number PHHY2017US018855, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 665976) on 23 Jan 2017. This report refers to a 59 years old female patient. Medical history and concomitant medication was reported as none. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer unknown, batch number: not reported) on 28 Oct 2016. On 08 Nov 2016 after vaccination, the patient experienced cold symptoms at first. By the next evening that is on 09 Nov 2016, the patient experienced chills, headache, body aches, on and off sweats, skin was sensitive to touch, congestion, stuffy head and sore throat. It was reported that, the events lasted through 14 Nov 2016. The outcome of the events was reported as complete recovery. The seriousness of the events was reported as non serious and causality was not reported.
Age: 59.0
Sex: F
Vaccine: FLUX
Symptoms: Pain, Respiratory tract congestion, Sinus congestion
Clinical narrative: Case number PHHY2017US018855, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 665976) on 23 Jan 2017. This report refers to a 59 years old female patient. Medical history and concomitant medication was reported as none. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer unknown, batch number: not reported) on 28 Oct 2016. On 08 Nov 2016 after vaccination, the patient experienced cold symptoms at first. By the next evening that is on 09 Nov 2016, the patient experienced chills, headache, body aches, on and off sweats, skin was sensitive to touch, congestion, stuffy head and sore throat. It was reported that, the events lasted through 14 Nov 2016. The outcome of the events was reported as complete recovery. The seriousness of the events was reported as non serious and causality was not reported.
Age: 71.0
Sex: F
Vaccine: FLUX
Symptoms: Diarrhoea, Injection site erythema, Injection site pain, Injection site swelling, Sleep disorder
Clinical narrative: Case number PHHY2017US019055, is initial spontaneous report received from a consumer via vaccine adverse event reporting system (VAERS: 666011) on 23 Jan 2017. This report refers to a 71-year-old female patient. Medical history was not reported. Concomitant medication was not reported. The patient was vaccinated with Seasonal Influenza Virus vaccine Seasonal INN (manufacturer unknown and batch number not reported) on an unknown date in Oct 2016 and the patient received PRALUENT (lot number: 6F040A, expiration date: 31 Mar 2017) for the treatment of an unknown indication from 02 Nov 2016 at 17:00 hrs, at a dose of 75 mg. On 02 Nov 2016, 1 week after vaccination, the patient had experienced diarrhea, racquetball sized, round, red, raised swelling area at the injection site on her right upper leg and had little sore, on same day few hours after the patient had taken the PRALUENT. On 02 Nov 2016, 1 week after vaccination, the patient woke up during the night with diarrhea, on same day few hours after the patient had taken the PRALUENT. Laboratory investigations and corrective treatments were not reported. On an unspecified date, patient recovered from event diarrhea and woke up during the night. On 02 Nov 2016, patient recovered from event racquetball sized, round, red, raised swelling area at the injection site which lasted for approximately half an hour and went away and sore. Seriousness of the events were reported as non serious and causality was not reported.
Age: 67.0
Sex: F
Vaccine: FLUX, PNC13
Symptoms: Injected limb mobility decreased, Injection site erythema, Vaccination site pain, Vaccination site reaction, Vaccination site swelling
Clinical narrative: Case number PHHY2017US019906, is an initial spontaneous report received from a consumer via Vaccine Adverse Events Reporting System (VAERS reference number: 666215) on 23 Jan 2017. This report refers to a 67 years old female patient. Medical history was not reported. Concomitant medication was not reported. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer unknown, batch number: not reported) and PREVNAR 13 (other manufacturer), batch number: not reported) on an unknown date in Nov 2016. On an unknown date in Nov 2016 after vaccination, the patient experienced vaccination site reaction with initially limited arm movement and then progressed to becoming swollen and red. The patient since then treated with ADVIL for the swelling and pain as well as applied an ice pack to the vaccination site. The final outcome of the events was reported as unknown. The seriousness of the events was reported as non serious and causality was not reported.
Sex: M
Vaccine: FLUX, PNC13
Symptoms: Injection site pain, Injection site rash, Injection site swelling
Clinical narrative: Case number PHHYUS019191, is an initial spontaneous report received from a pharmacist via a Pfizer sales representative via Vaccine Adverse Event Reporting System (VAERS reference number: 666217) website on 23 Jan 2017. This report refers to a male patient of unspecified age. Past medical history was not reported and concomitant medications were not reported. The patient was vaccinated with seasonal influenza virus vaccine INN (unknown manufacturer, batch number: not reported) on an unspecified date. The patient was also vaccinated with PREVNAR 13 (batch number: not reported) at a dose of 0.5 ml on an unspecified date. On an unspecified date after vaccination a reaction as it looked like larger than normal rash, swelling and pain at the site of injection. The outcome of the events was unknown. The seriousness and causality of the events were not reported.
Age: 79.0
Sex: F
Vaccine: FLUX
Symptoms: Acne, Breast pain, Erythema, Musculoskeletal pain, Nipple pain
Clinical narrative: Case number PHHY2017US018400 is an initial spontaneous report received from other healthcare professional via vaccine adverse event reporting system (Vaers number: 666376) website on 23 Jan 2017. This report refers to 79 year old female patient. Medical history was not reported; concomitant medication included Simvastatin, Lisinopril, Aspirin, Multi vitamin and Latanoprost, Vit E, Clonazepam. The patient was vaccinated with Seasonal influenza virus vaccine INN (manufacturer unknown) on 26 Oct 2016. On 01 Nov 2016, the patient experienced pain in right shoulder blade and around to right breast and nipple. The patient had visited emergency room (date not reported) and had US to rule out gall bladder but still had pain. There was no rash but internal pain. Patient had a red spot on her shoulder blade but no oozing, had a spot on right nipple with a white head type of thing and lots of pain. The outcome of the events was reported as condition unchanged, seriousness of the events was non serious and causality of the events was not reported.
Age: 79.0
Sex: F
Vaccine: FLUX
Symptoms: Ultrasound biliary tract normal
Clinical narrative: Case number PHHY2017US018400 is an initial spontaneous report received from other healthcare professional via vaccine adverse event reporting system (Vaers number: 666376) website on 23 Jan 2017. This report refers to 79 year old female patient. Medical history was not reported; concomitant medication included Simvastatin, Lisinopril, Aspirin, Multi vitamin and Latanoprost, Vit E, Clonazepam. The patient was vaccinated with Seasonal influenza virus vaccine INN (manufacturer unknown) on 26 Oct 2016. On 01 Nov 2016, the patient experienced pain in right shoulder blade and around to right breast and nipple. The patient had visited emergency room (date not reported) and had US to rule out gall bladder but still had pain. There was no rash but internal pain. Patient had a red spot on her shoulder blade but no oozing, had a spot on right nipple with a white head type of thing and lots of pain. The outcome of the events was reported as condition unchanged, seriousness of the events was non serious and causality of the events was not reported.
Sex: F
Vaccine: FLUX
Symptoms: Headache, Injection site erythema, Injection site swelling, Injection site warmth, Myalgia
Clinical narrative: Case number PHHY2017US019097, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (VAERS reference number: 666377) website on 23 Jan 2017. The report refers to a 09 years old female patient. Past medical history was not reported. Current conditions included as penicillin, OMNICEF and nickel. Concomitant medications was not reported. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer and batch number: not reported) on 13 Nov 2016. On the same day after vaccination, the patient experienced sore arm, swollen red and hot injection site, headache and muscle aches. The outcome of the events was reported as condition unchanged. The seriousness and causality of the events were not reported.